Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 33 results.
User Information
Export Records
  1. 1.   Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by 31P NMR
  2. Sharma,Alok; Pei, Jun; Yang, Yue; Dyba,Marcin; Smith,Brian; Rabara,Dana; Larsen,Erik; Lightstone, Felice C; Esposito,Dom; Stephen,Andy; Wang, Bin; Beltran, Pedro J; Wallace, Eli; Nissley,Dwight; McCormick, Frank; Maciag,Anna
  3. The Journal of Biological Chemistry. 2024, Jan 16; 300(2): 105650.
  1. 2.   Investigating the NRAS 5' UTR as a target for small molecules
  2. Balaratnam,Sumirtha; Torrey, Zachary R; Calabrese,Dave; Banco, Michael T; Yazdani, Kamyar; Liang, Xiao; Fullenkamp,Chris; Seshadri,Sri; Holewinski,Ronald; Andresson,Thorkell; Ferré-D'Amaré, Adrian R; Incarnato, Danny; Schneekloth,Jay
  3. Cell Chemical Biology. 2023, Jun 15; 30(6): 643-657.e8.
  1. 3.   Machine Learning Informs RNA-Binding Chemical Space
  2. Yazdani, Kamyar; Jordan, Deondre; Yang,Mo; Fullenkamp,Chris; Schneekloth,Jay; Calabrese,Dave; Boer, Robert E; Hilimire, Thomas A; Allen, Timothy E H; Khan, Rabia T
  3. Angewandte Chemie (International ed. in English). 2022, Dec 30;
  1. 4.   Structural insights of the conserved "priming loop" of hepatitis B virus pre-genomic RNA
  2. LeBlanc, Regan M; Kasprzak,Wojciech; Longhini, Andrew P; Olenginski, Lukasz T; Abulwerdi, Fardokht; Ginocchio, Stefano; Shields, Brigit; Nyman, Julie; Svirydava, Maryia; Del Vecchio, Claudia; Ivanic,Joseph; Schneekloth,Jay; Shapiro, Bruce A; Dayie, Theodore Kwaku; Le Grice,Stuart
  3. Journal of Biomolecular Structure & Dynamics. 2022, Jun 22; 40(20): 9761-9773.
  1. 5.   Inhibition of Nonfunctional Ras
  2. Nussinov,Ruth; Jang, Hyunbum; Gursoy, Attila; Keskin, Ozlem; Gaponenko, Vadim
  3. Cell Chemical Biology. 2021, Feb 18; 28(2): 121-133.
  1. 6.   Three-Color Imaging Enables Simultaneous Screening of Multiple RNA Targets on Small Molecule Microarrays
  2. Jordan,Deondre; Yang,Mo; Schneekloth,Jay
  3. Current protocols in chemical biology. 2020, Dec; 12(4): e87.
  1. 7.   Parallel Discovery Strategies Provide a Basis for Riboswitch Ligand Design
  2. Tran, Brandon; Pichling, Patricio; Tenney, Logan; Connelly, Colleen M; Moon, Michelle H; Ferré-D'Amaré, Adrian R; Schneekloth,Jay; Jones, Christopher P
  3. Cell chemical biology. 2020, OCT 15; 27(10): 1241-+.
  1. 8.   Creating and screening natural product libraries
  2. Wilson,Brice; Thornburg,Chris; Henrich,Curtis; Grkovic,Tanja; O'Keefe,Barry
  3. Natural product reports. 2020, JUL 1; 37: 893-918.
  1. 9.   Allosteric p97 inhibitors can overcome resistance to ATP-competitive p97 inhibitors for potential anti-cancer therapy
  2. Wang, Feng; Li, Shan; Gan, Taiping; Stott,Gordon; Flint,Andrew; Chou, Tsui-Fen
  3. ChemMedChem. 2020, APR 20; 15(8): 685-694.
  1. 10.   Using SHAPE-MaP to probe small molecule-RNA interactions
  2. Martin, Sarah; Blankenship, Carson; Rausch,Jason; Sztuba-Solinska, Joanna
  3. Methods (San Diego, Calif.). 2019, SEP 1; 167: 105-116.
  1. 11.   Second harmonic generation detection of Ras conformational changes and discovery of a small molecule binder
  2. Donohue, Elizabeth; Khorsand, Sina; Mercado, Gabriel; Varney, Kristen M; Wilder, Paul T; Yu, Wenbo; MacKerell, Alexander D; Alexander,Patrick; Van,Que; Moree, Ben; Stephen,Andy; Weber, David J; Salafsky, Joshua; McCormick, Frank
  3. Proceedings of the National Academy of Sciences of the United States of America. 2019, Aug 27; 116(35): 17290-17297.
  1. 12.   Evidence for ligandable sites in structured RNA throughout the Protein Data Bank
  2. Hewitt, William M.; Calabrese,Dave; Schneekloth,Jay
  3. BIOORGANIC & MEDICINAL CHEMISTRY. 2019, Jun 1; 27(11): 2253-2260.
  1. 13.   Targeting Non-coding RNA Sensitizes Cancer Cells to Drugs
  2. Yang,Mo; Schneekloth,Jay
  3. Trends in pharmacological sciences. 2019, May 20; pii: S0165-6147(19)30094-X.
  1. 14.   Measuring RNA-Ligand Interactions with Microscale Thermophoresis
  2. Moon, Michelle H.; Hilimire, Thomas A.; Sanders, Allix M.; Schneekloth, Jay
  3. BIOCHEMISTRY. 2018, Aug 7; 57(31): 4638-4643.
  1. 15.   Unequivocal determination of caulamidines A and B: application and validation of new tools in the structure elucidation tool box
  2. Milanowski, Dennis J.; Oku, Naoya; Cartner, Laura; Bokesch, Heidi; Williamson, R. Thomas; Sauri, Josep; Liu, Yizhou; Blinov, Kirill A.; Ding, Yuanqing; Li, Xing-Cong; Ferreira, Daneel; Walker, Larry A.; Khan, Shabana; Davies-Coleman, Michael T.; Kelley, Jim; McMahon, James B.; Martin, Gary E.; Gustafson, Kirk
  3. Chemical Science. 2018, Jan 14; 9(2): 307-314.
  1. 16.   Recent Advances in Targeting the HIV-1 Tat/TAR Complex
  2. Abulwerdi, Fardokht; Legrice, Stuart
  3. Current pharmaceutical design. 2017, Jun 15; 23(28): 4112-4121.
  1. 17.   Discovery of RNA Binding Small Molecules Using Small Molecule Microarrays
  2. Connelly, Colleen; Abulwerdi, Fardokht; Schneekloth, Jay
  3. Methods in Molecular Biology. 2017 1518: 157-175.
  1. 18.   High-throughput single-molecule screen for small-molecule perturbation of splicing and transcription kinetics
  2. Day, C. R.; Chen, H.; Coulon, A.; Meier, J. L.; Larson, D. R.
  3. Methods (San Diego, Calif.). 2016, 1-Mar; 96: 59-68.
  1. 19.   Evolution-Based Design of an Injectable Hydrogel
  2. Geisler, I. M.; Schneider, J. P.
  3. Advanced Functional Materials. 2012, Feb; 22(3): 529-537.
  1. 20.   Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells
  2. Bulut, G.; Hong, S. H.; Chen, K.; Beauchamp, E. M.; Rahim, S.; Kosturko, G. W.; Glasgow, E.; Dakshanamurthy, S.; Lee, H. S.; Daar, I.; Toretsky, J. A.; Khanna, C.; Uren, A.
  3. Oncogene. 2012, Jan; 31(3): 269-281.
  1. 21.   Quantitative Analysis of Phospholipids Using Nanostructured Laser Desorption Ionization Targets
  2. Colantonio, S.; Simpson, J. T.; Fisher, R. J.; Yavlovich, A.; Belanger, J. M.; Puri, A.; Blumenthal, R.
  3. Lipids. 2011, May; 46(5): 469-477.
  1. 22.   Pharmacophore Refinement Guides the Design of Nanomolar-Range Botulinum Neurotoxin Serotype A Light Chain Inhibitors
  2. Nuss, J. E.; Dong, Y. X.; Wanner, L. M.; Ruthel, G.; Wipf, P.; Gussio, R.; Vennerstrom, J. L.; Bavari, S.; Burnett, J. C.
  3. Acs Medicinal Chemistry Letters. 2010, Oct; 1(7): 301-305.
  1. 23.   Tautomerism in large databases
  2. Sitzmann, M.; Ihlenfeldt, W. D.; Nicklaus, M. C.
  3. Journal of Computer-Aided Molecular Design. 2010, Jun; 24(6-7): 521-551.
  1. 24.   Mechanisms of transcription factor selectivity
  2. Pan, Y. P.; Tsai, C. J.; Ma, B. Y.; Nussinov, R.
  3. Trends in Genetics. 2010, Feb; 26(2): 75-83.
  1. 25.   Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores
  2. Weidlich, I. E.; Dexheimer, T.; March, C.; Antony, S.; Pommier, Y.; Nicklaus, M. C.
  3. Bioorganic & Medicinal Chemistry. 2010, Jan; 18(1): 182-189.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel